Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
A few small trials and case reports used oral or parenteral GHK-Cu analogs
Clinical Applications While human trials are limited and 5-Amino-1MQ is not FDA-approved as a therapeutic agent, its mechanism and early research suggest potential benefits in: Weight management and body recomposition Adiposity reduction and fat loss Insulin sensitivity improvement Metabolic syndrome support NAD optimization and anti-aging protocols Cellular energy and endurance enhancement Adjunct to exercise or caloric restriction protocols It may be particularly relevant for individuals with stubborn fat loss resistance , age-related metabolic decline, or those using NAD-supportive therapies like NMN or NR
TABLE 2 Pharmacokinetic parameters of BPC157 in rats following intramuscular administrations of doses ranging between 5 and 120 g/kg (mean SD, n = 6)
Nutr Diabetes
Do not freeze the vial, and do not use the solution if it looks cloudy, discolored, or contains visible particles
US$ 27.51
US$ 26.51
US$ 23.44
US$ 26.65
US$ 28.35
US$ 28.67
